Neovasc Inc. Gross Margin

Gross Margin of NVCN for past 10 years: annual, quarterly and twelve month trailing (TTM) including Gross Margin growth rates and interactive chart. Gross profit margin shows the percentage of revenue that exceeds a company's costs of goods sold. It illustrates how well a company is generating revenue from the costs involved in producing their products and services. The higher the margin, the more effective the company's management is in generating revenue for each dollar of cost. Gross profit margin is calculated by subtracting the cost of goods sold from total revenue for the period and dividing that number by revenue. If a company has $200 million in revenue and $80 million in cost of goods sold, the gross margin is 60%.


Highlights and Quick Summary

  • Gross Margin for the quarter ending March 31, 2022 was 77.7% (a 7.28% increase compared to previous quarter)
  • Year-over-year quarterly Gross Margin decreased by -6.13%
  • Annual Gross Margin for 2021 was 78.19% (a 1.28% increase from previous year)
  • Annual Gross Margin for 2020 was 77.2% (a -1.14% decrease from previous year)
  • Annual Gross Margin for 2019 was 78.09% (a -1.23% decrease from previous year)
  • Twelve month Gross Margin ending March 31, 2022 was 77.11% (a -1.38% decrease compared to previous quarter)
  • Twelve month trailing Gross Margin decreased by -4.5% year-over-year
Trailing Gross Margin for the last four month:
31 Mar '22 31 Dec '21 30 Sep '21 30 Jun '21
77.11% 78.19% 80.77% 80.74%
Visit stockrow.com/NVCN for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Gross Margin of Neovasc Inc.

Most recent Gross Marginof NVCN including historical data for past 10 years.

Interactive Chart of Gross Margin of Neovasc Inc.

Neovasc Inc. Gross Margin for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 77.7%
2021 72.43% 76.57% 82.77% 83.98% 78.19%
2020 81.23% 75.97% 73.73% 76.62% 77.2%
2019 80.66% 72.43% 84.77% 75.42% 78.09%
2018 82.14% 79.88% 78.13% 74.29% 79.06%
2017 7.4% 52.02% 33.13% 45.41% 35.46%
2016 25.65% 27.44% 18.66% 27.96% 25.45%
2015 12.32% 36.64% 37.99% 30.25% 30.13%
2014 12.2% 40.05% 30.22% 50.32% 36.35%
2013 37.83% 40.82% 41.76% 38.85% 39.7%
2012 38.79% 36.48% 39.47% 49.12% 40.66%
2011 100.0% 39.24%

Business Profile of Neovasc Inc.

Sector: Healthcare
Industry: Medical Devices
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.